IPO > IPO details

< Back

ONYX BIOTEC LIMITED

IPO

Issue Price

₹58- ₹61

per equity share

Issue Size

34.44 lakhs

equity share

Face Value

₹ 10

per equity share

Market Lot

2000

equity share

Please note

Listing at NSE

ONYX BIOTEC LIMITED

Important Dates

IPO Open Date

13 Nov 2024

IPO Close Date

18 Nov 2024

Allotment Date

19 Nov 2024

Initiation of Refunds

20 Nov 2024

Credit of Shares to Demat Account

20 Nov 2024

IPO Listing Date

21 Nov 2024

UPI Mandate Expiry Date

18 Nov 2024

IPO Details

Onyx Biotec IPO issue size is 48.10 lakh equity shares. This IPO is offering entirely a fresh issue. The price band is decided at Rs 58 to Rs 61 per share. Onyx Biotec IPO 1 lot consists of 2000 shares. The minimum investment for the retail category is to be around Rs 122,000. The allotment status will be released on Tuesday, November 19, 2024. The listing will be on the NSE SME platform on Thursday, November 21, 2024. Onyx Biotec IPO registrar is Mas Services Limited. On the date of allotment, Investors can visit on Mas Services Limited website and, select the name of the company and enter PAN number or application ID to know their allotment status.

Don't let another opportunity slip away. Check your IPO status now!

Check Allotment Status

About ONYX BIOTEC LIMITED

Onyx Biotec Limited, established in 2005, is a prominent pharmaceutical company based in Himachal Pradesh, India. Specializing in the production of parenteral products, it offers a range of sterile solutions, including polyethene ampoules. Onyx Biotec has received recognition for its commitment to quality and innovation in drug manufacturing. Its focus on meeting healthcare needs places the company in an important position to supply essential medications across the region. With its strategic location near Solan, its distribution capabilities are well enhanced to provide efficient service delivery. As an exact brand name that encourages trust in the pharmacy market, Onyx Biotec continues to further the development of products while upholding regulatory rigour at its best, thus contributing substantially towards the health sector of India.

Parent Organisation

-

Founded

2005

Managing Director

Sanjay Jain

IPO Objectives

The company plans to use the Net Proceeds from the issue to upgrade its existing manufacturing Unit I to produce large-volume parentals for intravenous use, establish a high-speed carton packaging line at manufacturing Unit II for dry powder injections, repay or prepay a portion of its loans, and for general corporate purposes.

How to apply for IPO

  • Login to your Bigul account and select the issue in the current IPO section
  • Enter the number of lots and price at which you wish to apply for
  • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange
  • You will receive a mandate notification to block funds in your UPI app
  • Approve the mandate request on your UPI and funds will be blocked
Close

Let's Open Free Demat Account